Sara Elizabeth Townsley

Array ( [id] => 7230574 [patent_doc_number] => 20040156872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Novel nimesulide compositions' [patent_app_type] => new [patent_app_number] => 10/697703 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16977 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20040156872.pdf [firstpage_image] =>[orig_patent_app_number] => 10697703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835385 [patent_doc_number] => 20060247216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments' [patent_app_type] => utility [patent_app_number] => 10/532390 [patent_app_country] => US [patent_app_date] => 2003-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27604 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247216.pdf [firstpage_image] =>[orig_patent_app_number] => 10532390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649759 [patent_doc_number] => 20060135494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Methods of treating injuries of the nervous system associated with hemorrhage' [patent_app_type] => utility [patent_app_number] => 10/532039 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8459 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135494.pdf [firstpage_image] =>[orig_patent_app_number] => 10532039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11641022 [patent_doc_number] => 09662371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Treatment of autism and similar disorders' [patent_app_type] => utility [patent_app_number] => 10/530246 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8267 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10530246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793188 [patent_doc_number] => 20060013869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Electrospun amorphous pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/523835 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8542 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013869.pdf [firstpage_image] =>[orig_patent_app_number] => 10523835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726330 [patent_doc_number] => 20060057090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Cosmetic preparations with anitacterial properties' [patent_app_type] => utility [patent_app_number] => 10/521722 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9264 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057090.pdf [firstpage_image] =>[orig_patent_app_number] => 10521722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619977 [patent_doc_number] => 20060189511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Method for cytoprotection through mdm2 and hdm2 inhibition' [patent_app_type] => utility [patent_app_number] => 10/514338 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6476 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189511.pdf [firstpage_image] =>[orig_patent_app_number] => 10514338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233387 [patent_doc_number] => 20050256093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Branched polyamine steroid derivatives' [patent_app_type] => utility [patent_app_number] => 10/509911 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9956 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256093.pdf [firstpage_image] =>[orig_patent_app_number] => 10509911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7430189 [patent_doc_number] => 20040001883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Meloxicam suppositories' [patent_app_type] => new [patent_app_number] => 10/394088 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1314 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001883.pdf [firstpage_image] =>[orig_patent_app_number] => 10394088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911934 [patent_doc_number] => 20050175692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Pharmaceutical formulation comprising melatonin' [patent_app_type] => utility [patent_app_number] => 10/510625 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175692.pdf [firstpage_image] =>[orig_patent_app_number] => 10510625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060653 [patent_doc_number] => 20050003014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs' [patent_app_type] => utility [patent_app_number] => 10/494709 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2968 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003014.pdf [firstpage_image] =>[orig_patent_app_number] => 10494709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4450895 [patent_doc_number] => 07964218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Granular preparations for oral administration' [patent_app_type] => utility [patent_app_number] => 10/363680 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3371 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964218.pdf [firstpage_image] =>[orig_patent_app_number] => 10363680 [rel_patent_id] =>[rel_patent_doc_number] =>)